Home
Products
Learn
About
Pricing
Log In
LLY
Asset Logo

Eli Lilly and Company

πŸ‡ΊπŸ‡Έ NYSE/NASDAQ

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸƒ Esg

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

+ 75.70%
Annual Growth

5 years average annual capital growth

🌏

202
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Eli Lilly and Company is a medicine company, which discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity, and Zepbound. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. It is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD). It also owns a lead therapeutic molecule, FXR314.

πŸ“ˆ Performance

Price History*

+902.83%

1M

1Y

10Y

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$734.57

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in LLY

202

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

38 weeks

πŸ’΅ Average investment amount

$1,004

⏰ Last time a customer invested in LLY

21 hours
LLY investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

8%

100k - 150k

21%

50k - 100k

43%

Less than 50k

21%
πŸ‘Ά Age of investors

18 - 25

9%

26 - 34

43%

35 - 90

48%
πŸ™‹ Legal gender of investors

Female

69%

Male

31%

Pearlers who invest in LLY also invest in...

NVIDIA Corporation

NVDA

πŸ™Œ Performance (5Yr p.a)

278.61%

πŸ“Š Share price

$116.65 USD

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

πŸ™Œ Performance (5Yr p.a)

21.92%

πŸ“Š Share price

$65.77 USD

πŸ“ˆ HIGH PRICE GROWTH

πŸ™Œ Performance (5Yr p.a)

31.21%

πŸ“Š Share price

$198.53 USD

πŸ“ˆ HIGH PRICE GROWTH

πŸ™Œ Performance (5Yr p.a)

307.75%

πŸ“Š Share price

$298.26 USD

πŸ™Œ Performance (5Yr p.a)

629.09%

πŸ“Š Share price

$193.06 USD

Want more shares? Try these...

πŸ“Š Share price

$74.03 USD
Compare
Add to watchlist